Resources
- Summary of the Oral Complications Systematic Reviews
- Management Recommendations - Summary of Evidence Table
- Evidence-Based Management Strategies for Oral Complication from Cancer Treatment
- Predicting radiation dosimetric distribution in different regions of the jaw in patients receiving radiotherapy for squamous cell carcinoma of the tonsil
Systematic Reviews
- Systematic reviews and guidelines for oral complications of cancer therapies - current challenges and future opportunities
- Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC_ISOO - methodology and quality of the literature
- A systematic review of oral fungal infections in patients receiving cancer therapy
- A systematic review of viral infections associated with oral involvement in cancer patients - a spotlight on Herpesviridea
- A systematic review of dental disease in patients undergoing cancer therapy
- A systematic review of orofacial pain in patients receiving cancer therapy
- A systematic review of trismus induced by cancer therapies in head and neck cancer patients
- A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies - prevalence, severity and impact on quality of life
- A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies - management strategies and economic impact
- A systematic review of dysgeusia induced by cancer therapies
- Osteoradionecrosis in cancer patients - the evidence base for treatment-dependent frequency, current management strategies, and future studies
- A systematic review of bisphosphonate osteonecrosis (BON) in cancer
Past Workshops
Clinical Guidelines
- MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy
- Summary of the Oral Complications Systematic Reviews
- Management Recommendations - Summary of Evidence Table
- Evidence-Based Management Strategies for Oral Complication from Cancer Treatment
- International Conference: Oral Complications of Emerging Cancer Therapies April 14-15, 2009 Bethesda, Maryland USA Report authored by Jean Klastersky MD Professor, University of Brussels Chief of Medicine Service, Institut Jules Borde Brussels, Belgium.
- Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary
- Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline
© Copyright . ISOO All Rights Reserved. Site designed by OvertheAtlantic.com (Canada)
ota.studio